There are reasons to believe that the company will receive MRTP status, which enables the company to be the only company to sell and market VLN cigarettes. While investors have […]
The shares have fallen off lately, but this happens on a news-driven stock. It’s an attractive risk/reward play but the underlying story warrants patience but we still think that will […]
We’re about to enter the season for smallcaps, where they often gain most of the returns for the year. This year could have additional fuel due to the likelihood of […]
A long and interesting third quarter conference call has left us with considerable optimism about one of our small and risky stocks. The big change is the FDA’s intent to […]
Every portfolio should have a small-cap corner, stocks with a high-risk, high-reward profile. Ideally, this part should have a dozen or so, as you need only one or two successes. […]
Having unique IP that lets the company regulate nicotine levels of tobacco genetically, 22nd Century Group (XXII) acquires licenses in technology that can do the same for HTC levels in […]
22nd Century Group owns unique IP that enables it to produce cigarettes with low or very low nicotine levels. It is now allowed to sell these in the US under […]
There is no excerpt because this is a protected post.
While the market indexes are holding up, many stocks are in bear market territory. We think some of the stocks that have been sold off heavily are due for a […]